N,N-Bis(2-hydroxyethyl)-p-phenylenediami

BCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.

3,4,5-Tricaffeoylquinic acid may attenuate the TNF-α±- and LPS-stimulated production of inflammatory mediators in keratinocytes by suppressing the Toll-like receptor 4 expression-mediated activation of the Akt, ERK and NF-κB pathways, it may exert an inhibitory effect against the pro-inflammatory mediator-induced skin disease.